Dobrodosli na sajt Medjunarodnog centra za razvoj finansijskog trzistaDobrodosli na sajt Medjunarodnog centra za razvoj finansijskog trzista
O namaUsluge CentraProizvodi CentraSavetovanja i seminariNasi rezultatiNasi klijenti
Arhiva vesti
Zlatara Majdanpek i brojna imovina ponuđeni za 129 miliona dinara
Javno nadmetanje za ovu firmu zakazano je za 5. oktobar.
MAJDANPEK - Industrija za preradu Majdanpek u stečaju ponuđena je na prodaju kao pravno lice po početnoj ceni od 129,7 miliona dinara, objavila je Agencija za licenciranje stečajnih upravnika.

Najvažnija imovina su celina Zlatara Majdanpek u kojoj je više lokacija sa objektima, celina Megaplast u Donjem Milanovcu, poslovni prostori u Beogradu, Požarevcu, Boru, Knjaževcu, Valjevu, Zaječaru i Nišu, kao i stan od 61 kvadratni metar na Novom Beogradu.


Grad Pančevo sprema se da proda više nekretnina u javnoj svojini
Grad Pančevo sprema se da proda više nekretnina – javne gradske imovine.
Na spisku za prodaju javnim nadmetanjem su poslovni prostor od 492 m2 u Kačarevu, u ulici Maršala Tita 9.
Na prodajnoj listi su i poslovni prostor od 90 m2 u pančevačkoj ulici Žarka Zrenjanina, kao i lokal od 39 m2 u istoj ulici.

Prodavaće se i poslovni prostori od 31 m2 u Maksima Gorkog, lokali u ulicama 6. Oktobra, Veljka Vlahovića i Vojvode Radomira Putnika, te Cara Lazara koji su od 16 do 113 kvadratnih metara.


Javni dug Srbije 55,2 posto BDP-a na kraju jula
Na kraju 2020. godine, javni dug Srbije je iznosio 26,66 milijardi evra, što je činilo 57,4 procenta BDP-a.
BEOGRAD - Javni dug Srbije iznosio je na kraju jula ove godine 28,36 milijardi evra, što čini 55,2 posto bruto domaćeg proizvoda (BDP), objavilo je Ministarstvo finansija.

U odnosu na jun 2021, iznos javnog duga je povećan u julu za 100 miliona evra, dok je njegov udeo u BDP-u veći za 0,2 procentna poena.


NBS: Fitch maintains Serbia’s credit rating at BB+
The credit rating agency Fitch Ratings has maintained Serbia’s rating at BB+, one step away from investment grade, with a stable outlook for its further growth, the National Bank of Serbia (NBS) has announced.
BELGRADE – The credit rating agency Fitch Ratings has maintained Serbia’s rating at BB+, one step away from investment grade, with a stable outlook for its further growth, the National Bank of Serbia (NBS) has announced.

“Serbia’s rating is supported by a credible macroeconomic policy framework, relatively low inflation and higher foreign exchange reserves.

Fitch also emphasizes stronger governance, human development and GDP per capita compared with ‘BB’ medians.

Economic resilience to the pandemic shock, a limited increase in public debt, and the agency’s confidence in Serbia’s fiscal consolidation prospects are also supportive of the rating and the stable outlook,” the central bank said in a statement.

Fitch has revised upwards its real GDP growth projection for Serbia in 2021 from 5.2 pct to 6.3 pct and expects continued strong growth of 4.4 pct in 2022.

“Constant upward revisions of Serbia’s GDP growth forecasts by international financial institutions during the previous and this year only confirm that we were right in our initial estimates at the start of the pandemic,” said NBS Governor Jorgovanka Tabakovic.

“Just as we firmly stood behind our macroeconomic projections, which proved to be the most accurate, ever since the outbreak of the pandemic, we now hold that it is quite realistic that Serbia’s real GDP growth will reach minimum 6.5 pct this year, because the latest data suggest a possibly even better outcome.

And not only that, the NBS has revised for the first time its medium-term real GDP growth projection from the earlier 4 pct to 4–5 pct,” Tabakovic said.

“Fitch states that inflation in Serbia has averaged 2 pct over the past seven years, below the ‘BB’ median.

Having in mind the overall macroeconomic framework and current and expected trends, the agency expects inflation to stay low and stable in the years ahead,” the NBS statement said.

“Despite disrupted global supply chains and surging global prices of oil and other primary commodities, inflation in Serbia has remained within the bounds of the target tolerance band (3±1.5 pct).

Our projections indicate that it will stay within those bounds in the period ahead as well.

From mid-2022 it will recede to the lower part of the band, staying there until the end of the projection horizon.

At the same time, this corresponds to the estimates of leading international financial institutions”, Tabakovic also said.


Konvar kupio fabriku lekova Jugoremedija za 3,1 mil EUR
Društvo za projektovanje, proizvodnju, usluge, kontrolu kvaliteta i inženjering Konvar iz Beograda novi je vlasnik zrenjaninske fabrike lekova Jugoremedija, piše Danas. Kako se navodi, Konvar je Jugoremediju kupio od Investicionog fonda APS, tačnije firme Project one, koja je prošle jeseni kupila fabriku lekova za 3,1 mil EUR.

Project one je u međuvremenu oglasio prodaju Jugoremedije za 5,5 mil EUR i bilo je više zainteresovanih ulagača, među njima i novosadska firma Union medik koja je jedno vreme iznajmljivala ovaj pogon i tu proizvodila lekove.

Podaci o novom vlasniku registrovani su u APR-u, a izmene Statuta evidentirane su 14. juna, dok je preuzimanje fabrike nedavno počelo.

Prema saznanjima medija, u toku je raščišćavanje fabričkog kruga u Zrenjaninu i priprema pogona. Na pitanja o daljim planovima u firmi Konvar još nisu imali komentar, dok je stečajni upravnik Jugoremedije Radovan Savić rekao da su počeli ozbiljni radovi na pripremi fabrike.

- Ne koristim više kanceariju u Jugoremediji, ali ima još uvek stečajnih obaveza. U toku su dve parnice, sa dvostrano teretnim ugovorima vrednosti preko 200 miliona dinara. To su obaveze stečajne mase, iz koje bi trebalo i zaposleni da se namire - kazao je Savić za Danas.

Stečaj u zrenjaninskoj Jugoremediji uveden je u decembru 2012. godine a bankrotstvo proglašeno u novembru 2016. godine. Organizovano je 14 prodaja.

Odbor poverilaca je tokom 2017. i 2019. godine dao saglasnost da se prodaja stečajnog dužnika kao pravnog lica obavi metodom neposredne pogodbe. Tek u avgustu 2020. godine Jugoremedija je dobila novog vlasnika, kada je fabriku kupio investicioni fond za 364,5 miliona dinara i pobedio u nadmetanju.

Kupljena je kao stečajni dužnik i kao pravno lice, nakon čega je Privredni sud u Zrejaninu obustavio stečajni postupak.


Dinar-to-euro exchange rate at RSD 117.5638
The Serbian dinar’s official median exchange rate against the euro is 117.5638 dinars for one euro on Monday, which is a slight change from Friday, the National Bank of Serbia said.
BELGRADE – The Serbian dinar’s official median exchange rate against the euro is 117.5638 dinars for one euro on Monday, which is a slight change from Friday, the National Bank of Serbia said.

The dinar is steady against the euro m-o-m, y-o-y and relative to the beginning of the year.

The dinar’s indicative exchange rate against the dollar rose by 0.1 pct to 98.8679 dinars for one dollar on Friday.

The dinar was up by 0.5 pct against the dollar m-o-m and by 0.4 pct y-o-y, declining by 3.2 pct relative to the beginning of the year.


Konvar bought the Jugoremedija drug factory for EUR 3.1m
The company for design, production, services, quality control and engineering Konvar from Belgrade is the new owner of the Zrenjanin drug factory Jugoremedija, newspaper Danas reports. As it is stated, Konvar bought Jugoremedija from the APS Investment Fund, more precisely the company "Project one", which bought the drug factory last fall for EUR 3.1 million.

Project one, meanwhile, announced the sale of Jugoremedija for 5.5m euros, and there were several interested investors, including Union Medik from Novi Sad, company which used to lease this plant and produced drugs there for some time.

Data on the new owner were registered in the SBRA, and changes to the Statute were recorded on June 14, whereas the takeover of the factory began recently.

According to the media, the factory compound in Zrenjanin is being cleared and the plant is being prepared. They have not yet answered questions about further plans for the company Konvar, while the bankruptcy trustee of Jugoremedija, Radovan Savic, said that serious works on the preparation of the factory have begun.

Insolvency in Zrenjanins Jugoremedija was declared in December 2012, and bankruptcy was declared in November 2016. Total of 14 sales have been organized.


"Mali" akcionari
Emitenti
Posrednici
Investitori
Proizvodi Centra
Arhiva vesti
Kontaktirajte nasKnjiga gostijuMapa sajta